CAY10554

CAY10554

CAT N°: 10010301
Price:

From 95.00 80.75

Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising therapeutic targets for cancer and neurodegenerative diseases. Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising therapeutic targets for cancer and neurodegenerative diseases. CAY10554 is a potent inhibitor of Cdk5 and Cdk2, with IC50 values of 64 and 98 nM, respectively.{15079}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • N-[5-(1-methylethyl)2-thiazolyl]-benzeneacetamide
  • Correlated keywords
    • cell cycle Cdk5 Cdk2 inhibitors inhibits inhibition cancers BML 259 BML259 CDKs neurodegenerative diseases
  • Product Overview:
    Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising therapeutic targets for cancer and neurodegenerative diseases. Cyclin-dependent kinases (CDKs) are key regulators of cell cycle progression and are therefore promising therapeutic targets for cancer and neurodegenerative diseases. CAY10554 is a potent inhibitor of Cdk5 and Cdk2, with IC50 values of 64 and 98 nM, respectively.{15079}

We also advise you